ARGX Earnings

ARGX reported its earnings on 2026-03-02, showcasing a revenue of against an estimate of 1.25B, resulting in a 0% surprise. The EPS was 0, surpassing the expected 6.2 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following ARGX's earnings announcement on 2026-03-02, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, ARGX's stock price tends to shift by an average of -1.15% in the 10 days leading up to earnings and +1.00% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate ARGX’s annual revenue to reach 1.28B, while the EPS is projected at 5.74. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 1.22% and EPS estimates Revise Upward by 0.76% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between ARGX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 1.22%, while EPS estimates moved Revise Upward by 0.76% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ARGX's stock price typically moves by -1.15% in the 10 days before its earnings and +1.00% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 5.74 and revenue of 1.28B.

The earnings call highlights strong product development, market expansion, and positive feedback on VYVGART. Despite some uncertainties, the optimistic guidance, strategic pipeline expansion, and growing market penetration suggest a positive outlook. The Q&A session reinforces confidence in product growth and market strategy, with promising updates on trials and potential new indications. However, some management responses were vague, which could temper enthusiasm slightly. Overall, the sentiment leans positive, with potential for stock price appreciation in the short term.